Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Lisa Domegan, Simon de Lusignan et al.|Eurosurveillance|2021Cited by 55
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ projectMarc Rondy, Marta Valenciano, Amparo Larrauri et al.|Eurosurveillance|2017Cited by 41
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 seasonMarc Rondy, Alain Moren, Alin Gherasim et al.|Eurosurveillance|2017Cited by 35
Measuring the impact of influenza vaccination programmes among the elderly population in Spain, the Netherlands and Portugal, 2015-2018Clara Mazagatos, Marta Valenciano, Ausenda Machado et al.|Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)|2019Cited by 1